Foot‐and‐mouth disease (
FMD
) is an economically important, highly contagious disease of cloven‐hoofed animals characterised by the appearance of vesicles (blisters) on the feet and in, and around, the mouth. The causative agent, foot‐and‐mouth disease virus (
FMDV
), was the first mammalian virus to be discovered. It has a ribonucleic acid (
RNA
) genome enclosed within a protein coat (capsid). The virus replicates very rapidly within the cytoplasm of cells. The
RNA
genome has to function both as a messenger
RNA
(
mRNA
) and as a template for
RNA
replication. The
RNA
encodes a single large polyprotein that is processed, by virus‐encoded proteases, to about 12 mature products (plus functionally important precursors) that are required for virus replication and assembly. Some of these viral proteins modify host cell activities to block antivirus defence systems. Thus, this small virus displays a remarkably complex array of biological activities.
Key Concepts
Foot‐and‐mouth disease has worldwide economic importance.
Foot‐and‐mouth disease virus (FMDV) is able to infect a wide range of different cloven‐hoofed animals.
Seven different serotypes of FMDV are known and there is considerable antigenic diversity within each serotype.
FMDV uses specific cell‐surface molecules (including specific integrins) as receptors to gain entry into cells.
The viral RNA is sufficient to initiate an infection.
The RNA displays diverse activities, as a messenger RNA, as a template for RNA replication and as the genome.
The virus‐encoded polyprotein is processed by proteases present within itself to make about 12 different mature products (plus important precursors).
Viral proteins are required both for viral RNA replication and virus assembly; in addition, some also modify specific cellular functions in order to block host antiviral responses.
Current vaccines rely on the production and then chemical inactivation of infectious virus.
Non‐infectious empty capsid particles can be produced, which are candidates as new, safer vaccines.